INTRODUCTION AND OBJECTIVES: Prostate Sparing cystectomy is a valid option for the treatment of patient with bladder cancer provided that strict selection criteria are used. Although that there is a uniform agreement on excluding patients with bladder neck tumors as well as patients with suspicious prostate that may harbor prostatic carcinoma, there has not been a standardized consensus on how to safely exclude them. Furthermore, the exclusion of other criteria such as carcinoma in situ, tumor characteristics and presence of preoperative hydronephrosis have not been clearly elucidated.
METHODS: We retrospectively reviewed our laparoscopic/robotic assisted laparoscopic prostate sparing cystectomy series to evaluate our method of selecting patients.
RESULTS: Between 2001 and 2011, 60 patients were treated with laparoscopic or robotic PSC for muscle invasive or recurrent non muscle invasive bladder cancer. Mean follow up time was 76.9 months AE33.3SD. When the preoperative PSA cut off value for biopsy was ¼ 4ng/ dl; prostatic adenocarcinoma was detected on final pathology in 2 patients and arised de novo in 1 patient. When the value was lowered to 2.5ng/dl, no patient had incidental prostatic carcinoma and none developed de novo carcinoma. Distant/solitary carcinoma in situ was associated with more recurrences and so did preoperative hydronephrosis. Tumor grade, size and number were not associated with more recurrences.
CONCLUSIONS: The presence of any carcinoma in situ should be a contraindication to prostate sparing cystectomy. In addition to standard prostatic evaluation, a cut off PSA value of ¼ 2.5ng/dl for biopsy can eliminate any chance of harboring or developing a prostatic cancer. (PSC) is a controversial subject in the management of bladder cancer. Some authors believe it is a valid option in certain selected cases, while others believe that it carries significant risks. One of the arguments against sparing the prostate was the observation that it has unusually high rate of distant metastasis when compared to radical cystectomy. It was speculated that metastatic diffusion through prostatic veins can occur during endoscopic prostatic resection prior to surgery. we aimed to evaluate retrospectively, whether the different approaches to the prostatic adenoma prior to prostate sparing cystectomy have an impact on the rate of metastasis.
Source of
METHODS: Between October 1992 and December 2011, 160 cases with bladder cancer were treated with prostaste sparing cystectomy at our institution. Out of these; 100 patients (62.5%) had their prostate managed with TURP while 60 patients (37.5%) were managed by prostatic enucleation during cystectomy using Millin's technique. A minimum of 5 years follow up was available.
RESULTS: Mean patient age was 62 years for the TURP group and 60 years for the Millin's group. Mean postoperative follow up available was 64 months and 78 months for TURP and Millin's group respectively.
Postoperative pathological stage for the TURP group was ¼ pT1N0 in 24% , pT2N0 in 40%, ¼ pT3N0 in 23% and N+ in 13% ; compared to the Millin's group where the pathological stage was ¼ pT1N0 in 40 %, pT2N0 in 30%, ¼ pT3N0 in 22% and N+ in 8%. Overall survival rates at 5 years were 67% and 88% for the TURP and the Millin's groups respectively. The 5 years recurrence free survival rates for the TURP group were 77% for pT2 N0 or less, 44% for pT3 N0 or greater and 22% for pN+ disease. Regarding the Millin's group, the recurrence free survival rates were 86% for pT2 N0 or less, 75% for pT3 N0 or greater and 40% for pN+ disease. The local recurrence rates were 6.2 % and 11.7 % for the TURP and the Millin's groups respectively, and the respective distant recurrence rate was 34% and 16.7% .( p¼0.001) CONCLUSIONS: These results further support previous suggestions that TURP may contribute to the dissemination of tumor cells in bladder cancer patients.
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PD67-04 EARLY AND LATE COMPLICATIONS OF ROBOTIC RADICAL CYSTECTOMY AND INTRACORPOREAL URINARY DIVERSION
Sameer Chopra*, Fatima Hussain, Andre Abreu, Nariman Ahmadi, Andre Berger, Inderbir Gill, Monish Aron, Mihir Desai, Los Angeles, CA INTRODUCTION AND OBJECTIVES: To present 90 day perioperative complications stratified by urinary diversion type in patients undergoing robotic radical cystectomy (RRC) and completely intracorporeal urinary diversion (ICD).
METHODS: An IRB approved protocol allowed for review and analysis of data from 216 patients undergoing RRC-ICD between July 2010 to March 2016 from a single institution's bladder cancer database. Perioperative complications were categorized as early (<30 days) or late (0-90 days) and complication severity was classified using the Clavien-Dindo system.
RESULTS: A total of 174 men and 42 women with a median age (range) of 71 (35-94) years and a median body mass index (range) of 26.8 (16.0-44.5) kg/m2 underwent RRC-ICD. Orthotopic neobladder was performed in 68 patients (31.5%). The median postoperative length of stay (range) was 6 days (2-47). Early (<30 days) and late complications (0-90 days) occurred in 147 (68.1%) and 175 (81.0%) patients, respectively. A total of 30 patients (13.9%) required perioperative blood transfusion(s). Of those, 24 (16.2%) had ileal conduits and 6 (8.8%) had neobladders. The perioperative mortality was 1.9%. Moreover, 7.9 % patients developed an uretero-enteric stricture over a median follow-up (range) of 11.8 months (0.0-65.3). Complications are detailed in the corresponding table. CONCLUSIONS: Robotic radical cystectomy with complete intracorporeal urinary diversion is safe and technically feasible with acceptable perioperative morbidity. Prospective randomized trails comparing intracorporeal urinary diversion versus open diversion are necessary to compare peri-operative morbidity.
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